Screening of Estrogenic and Antiestrogenic Effects of Estradiol, Bisphenol A, and Fulvestrant Using 2D and 3D Breast Cancer Cell Systems With a Luciferase Reporter Gene Assay
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.70168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Valentina Monteleone und 19 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Phenols, Estradiol, Breast Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Health.
Abstract (Originalsprache)
Endocrine‐disrupting chemicals (EDCs) like bisphenol A (BPA) pose health risks by interfering with hormones. This study develops and utilizes in vitro 2D and 3D cell models to evaluate the estrogenic and antiestrogenic properties of compounds. Human breast cancer cell lines T47D and MCF7, stably transfected with a luciferase reporter gene (ERE‐LUC), were first compared in 2D. Due to the significantly higher sensitivity and responsiveness observed in the T47D line during preliminary 2D screenings, this cell line was exclusively selected for the development of the 3D spheroid model. Cells were treated with 17 β ‐estradiol (E2), BPA, and Fulvestrant (FUL) to assess cell viability and luciferase activity. In 2D models, T47D ERE‐LUC cells showed higher responsiveness than MCF7 ERE‐LUC, which failed to show significant luciferase induction with E2. In the 3D T47D model, cells exhibited significant and robust changes in luciferase activity in response to E2 and BPA, highlighting the enhanced fidelity of 3D cultures in replicating tissue conditions compared to their 2D counterparts. The study highlights the effectiveness of 3D models over 2D in evaluating estrogenic activity. Specifically, the 3D T47D ERE‐LUC system serves as a superior, sensitive, and reliable platform for screening EDCs, offering benefits in cost, data speed, and reduced in vivo reliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy.
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Laboratorio di Controllo di Prodotti Biologici, Farmaceutici e Convalida di Processi Produttivi, via A. Bianchi 9, Brescia, Italy.
ORCID-Profile: Valentina Monteleone, Marcoccia Daniele, Flavia Silvia Galli, Romano Zilli
Förderung
- Ministry of Health
Zitieren
APA
Monteleone, V., Barbaro, K., Elisa, I., Daniele, M., Bisegna, S., Mollari, M., Galli, F. S., Cittadini, M., Zepparoni, A., Caciolo, D., Sittinieri, S., Altigeri, A., Alimonti, C., Ciurli, G., Cimmino, A., Cortese, F. M., Sagrafoli, D., Villa, R., Zilli, R., & Scicluna, M. T. (2026). Screening of Estrogenic and Antiestrogenic Effects of Estradiol, Bisphenol A, and Fulvestrant Using 2D and 3D Breast Cancer Cell Systems With a Luciferase Reporter Gene Assay. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70168
Vancouver
Monteleone V, Barbaro K, Elisa I, Daniele M, Bisegna S, Mollari M, et al. Screening of Estrogenic and Antiestrogenic Effects of Estradiol, Bisphenol A, and Fulvestrant Using 2D and 3D Breast Cancer Cell Systems With a Luciferase Reporter Gene Assay. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70168
BibTeX
@article{Monteleone2026,
author = {Monteleone, Valentina and Barbaro, Katia and Elisa, Innocenzi and Daniele, Marcoccia and Bisegna, Sofia and Mollari, Marta and Galli, Flavia Silvia and Cittadini, Marina and Zepparoni, Alessia and Caciolo, Daniela and Sittinieri, Stefania and Altigeri, Annalisa and Alimonti, Cristian and Ciurli, Ginevra and Cimmino, Alessio and Cortese, Francesca Maria and Sagrafoli, Daniele and Villa, Riccardo and Zilli, Romano and Scicluna, Maria Teresa},
title = {Screening of Estrogenic and Antiestrogenic Effects of Estradiol, Bisphenol A, and Fulvestrant Using 2D and 3D Breast Cancer Cell Systems With a Luciferase Reporter Gene Assay},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70168}
}
EUVIMED